Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Extraction of Sequence Conservation Features for the Prioritization of Candidate Single Amino Acid Polymorphisms

Prioritization of Candidate Nonsynonymous Single Nucleotide Polymorphisms via Sequence Conservation Features

Prioritisation of Candidate Single Amino Acid Polymorphisms Using One-Class Learning Machines.

Integrating sequence conservation features and a domain-domain interaction network to detect disease-associated nsSNPs

Sequence-Based Prioritization of Nonsynonymous Single-Nucleotide Polymorphisms for the Study of Disease Mutations

Identification of Disease-Related Nssnps Via the Integration of Protein Sequence Features and Domain-Domain Interaction Data.

Improved Detection of Rare Genetic Variants for Diseases

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Integrating Multiple Genomic Data to Predict Disease-Causing Nonsynonymous Single Nucleotide Variants in Exome Sequencing Studies

Regsnps: a Strategy for Prioritizing Regulatory Single Nucleotide Substitutions.

Predicting functional impact of single amino acid polymorphisms by integrating sequence and structural features

Prioritizing Genomic Variants Pathogenicity Via DNA, RNA, and Protein-Level Features Based on Extreme Gradient Boosting

Prioritization of Nonsynonymous Single Nucleotide Variants for Exome Sequencing Studies Via Integrative Learning on Multiple Genomic Data

Identification of Disease-specific Single Amino Acid Polymorphisms Using a Simple Random Forest at Protein-level

A Novel SNP-set Analytical Method Without Distinguishing Common Variants or Rare Variants in Genome-Wide Association Study

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

Finding New Structural and Sequence Attributes to Predict Possible Disease Association of Single Amino Acid Polymorphism (SAP).

Leveraging Multiple Genomic Data to Prioritize Disease-Causing Indels from Exome Sequencing Data

Incorporating functional annotation information in prioritizing disease associated SNPs from genome wide association studies

Identification of Deleterious Single Amino Acid Polymorphism Using Sequence Information Based on Feature Selection and Parameter Optimization